SANGUINE CORP. (SGNC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Profiteer who wrote (84)	6/8/1998 11:41:00 PM
From: chirodoc	Read Replies (1) of 5402

when i talked about the side effects this is what i was referring to. now, we need to find out if dr. d's magic potion prevents this reaction. notice that long term use of the solution caused problems. dr. d's elixir may be what we are looking for. curtis Ophthalmic Surg Lasers 1996 May;27(5):395-396 Pupillary block glaucoma due to residual perfluoro-decalin. Alster Y, Ben-Nun Y, Loewenstein A, Lazar M Department of Ophthalmology, Tel-Aviv Medical Center, Tel-Aviv, Israel. Perfluorocarbon liquids are used in vitreoretinal surgery and should be removed by the end of surgery. Removal is not always achieved and a few cases of complications resulting from perfluorocarbon liquid residues have been reported. The authors report a unique case of pupillary block glaucoma resulting from perfluoro-decalin residue in the anterior chamber that blocked a surgical coloboma of the iris at the 6-o'clock position. The perfluoro-decalin residue dissolved spontaneously with antiglaucoma treatment and no surgical intervention was needed. When perfluorocarbon liquids are used during pars plana vitrectomy, the possibility of silicone-induced pupillary block in the presence of an inferior iris coloboma should not be overlooked.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next